Find and verify BlueRock Therapeutics employee emails, phone numbers, social links, and more in the
ContactOut
search portal
BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock’s Cell+Gene platform harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications. BlueRock’s cell differentiation technology recapitulates the cell’s developmental biology to produce native cell therapies which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock was founded in 2016 by Versant Ventures and capitalized with one of the largest-ever Series A financings in biotech history by Bayer AG and Versant. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to...
BlueRock Therapeutics is an engineered cell therapy company with a mission to develop regenerative medicines for intractable diseases. BlueRock’s Cell+Gene platform harnesses the power of cells for new medicines across neurology, cardiology and autoimmune indications. BlueRock’s cell differentiation technology recapitulates the cell’s developmental biology to produce native cell therapies which are further engineered for additional function. Utilizing these cell therapies to replace damaged or degenerated tissue brings the potential to restore or regenerate lost function. BlueRock was founded in 2016 by Versant Ventures and capitalized with one of the largest-ever Series A financings in biotech history by Bayer AG and Versant. BlueRock’s culture is defined by scientific innovation, the highest ethical standards and an urgency to bring transformative treatments to all who would benefit. The company strives to be a top employer of scientific talent, empowering every member of the team to make meaningful and lasting contributions to the burgeoning field of regenerative medicine. Become a BlueRocker! We are expanding our BlueRock team at all locations. Contact us via LinkedIn or our website to learn about rewarding career opportunities.
General Counsel & Chief Compliance Officer | Strategic Partner - Corporate Governance | Business Development | Litigation | Compliance Program Development
ContactOut is used by 76% of Fortune 500 companies
“This is such a great and simple tool to use.”
Tobia St Germain
Recruitment Coordinator, Google
"Find personal mails seamlessly. Thanks for this tool!"
Ekin Bayildiran
Executive Search, JP Morgan
“Great email tool. I've used a few other services and ContactOut is the easiest one to use.”
Jon Nowakowski
Sr. Recruiter, Robert Half
The market leader in coverage and accuracy
Contact details for 75% of professionals at 99% accuracy.
“ContactOut worked really well for us. A great tool; we use it daily.”
Amy Stephenson
Senior Consultant, Randstad
“Contact Out has tripled the yield to our InMail strategy traditionally exclusively on LinkedIn, which isn't delivering us ROI anymore. Great product!”
Ryan Brogan
Sr. Manager of Global Recruiting, WarnerMedia
“This is definitely my preferred extension for finding email addresses. It requires the least amount of effort to help find information needed. Keep up the great work!”
Suzanne Huynh
Associate, PwC
Access contact details others can't get
Other vendors purchase contact lists that have been resold hundreds of times. At ContactOut we source, store and refresh our data first hand.
“Love this extension and would recommend it to anyone looking for a tool to find email addresses.”
Evan M. Wolfson
National Sales Manager, Yelp
“Love it! I use it every day.”
Camille Verdier
Producer, CNN
“Excellent product, very small chance of error.”
Farida Charania
Sr. Recruiter, HSBC
Outreach CRM
Find emails on Linkedin and Github. Save profiles. Send email campaigns.